CompletedNot Applicable

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Switzerland46 participantsStarted 2020-04-01

Plain-language summary

Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. To control air leak, there are two different products certified since years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and Neoveil® in patients with PAL.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a pulmonary air leak following open lung surgery, regardless of whether an anatomical or atypical resection was performed * Patients who are able to decide for themselves whether to participate in the study or not ( for example due to language problems, mental disorders, dementia of the participant) * Patients who are not family member or employee of the investigator Exclusion Criteria: * Inability to follow the procedures of the study, for example, due to language problems, mental disorders, dementia of the participant * Enrolment of the investigator, his/her family members, employees and other dependent persons

What they're measuring

time required till air leak closure has occurred (hours)

Timeframe: end of the operation (0 hours) until removal of the chest tubes or re-operation in case of prolonged air leak (first postoperative day)

Trial details

NCT IDNCT04065880

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-01

View on ClinicalTrials.gov More Prolonged Air Leak trials